Article info

PDF
MHRA Drug Safety Update: denosumab (Xgeva) and rebound hypercalcaemia

Citation

MHRA Drug Safety Update: denosumab (Xgeva) and rebound hypercalcaemia

Publication history

  • First published October 8, 2018.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.